BALTIMORE--(BUSINESS WIRE)--Ameritox, Ltd., the U.S. leader in pain prescription urine drug monitoring, today announced its addition of the industry’s most advanced, most sensitive analytical method for detecting prescription pain medications: multiplexing liquid chromatography tandem mass spectrometry (LC-MS/MS). Ameritox has implemented the Thermo Scientific TSQ Quantum Access™ triple quadrupole mass spectrometer with the Aria™ TLX-4 multiplexing system to analyze fentanyl and opiates, and will soon add benzodiazepines. The TurboFlow™ technology in the Aria TLX-4 greatly reduces specimen preparation time when compared to standard LC-MS/MS systems. By installing this Thermo Scientific TSQ Quantum Access and Aria TLX-4 analytical system, Ameritox remains the industry leader in being able to offer the most sensitive analyses and rapid turnaround times.
